Loss of the NF-κB2 (p100/52) component of NF-κB accelerates lymphoma development in Eμ-Myc transgenic mice [29], while activation of the IKK2/NF-κB pathway inhibits lymphoma formation [28]. The gene discussed is NFKB2; the disease is lymphoma.